Comorbidities and causes of death of patients with asbestosis

Keskitalo, Eerika; Salonen, Johanna; Nurmi, Hanna; Vähänikkilä, Hannu; Kaarteenaho, Riitta (2022-12-22)
 
Avaa tiedosto
Lataukset: 

URL:
https://doi.org/10.1097/JOM.0000000000002777

Keskitalo, Eerika
Salonen, Johanna
Nurmi, Hanna
Vähänikkilä, Hannu
Kaarteenaho, Riitta
Wolters Kluwer
22.12.2022

Keskitalo, Eerika BM; Salonen, Johanna MD, PhD; Nurmi, Hanna MD, PhD; Vähänikkilä, Hannu PhD; Kaarteenaho, Riitta MD, PhD. Comorbidities and Causes of Death of Patients With Asbestosis. Journal of Occupational and Environmental Medicine 65(4):p 349-353, April 2023. | DOI: 10.1097/JOM.0000000000002777

https://rightsstatements.org/vocab/InC/1.0/
© 2022 American College of Occupational and Environmental Medicine.
https://rightsstatements.org/vocab/InC/1.0/
doi:https://doi.org/10.1097/JOM.0000000000002777
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi-fe2023050841871
Tiivistelmä

Abstract

Objective: Comorbidities are common and affect the prognosis of patients with interstitial lung diseases, but few previous studies have investigated patients with asbestosis.

Methods: We collected comorbidities and death causes of 116 patients with asbestosis treated in Oulu University Hospital. Causes of death were confirmed by autopsy in 68% of the cases.

Results: The most common comorbidities of asbestosis patients were pleural plaques (96%) and coronary artery disease (CAD; 67%). The prevalence of rheumatoid arthritis was 8.6%. The most common underlying causes of death were asbestosis (36%), CAD (24%), and lung cancer (LC) (10%). CAD and LC were associated with shorter survival in adjusted analyses.

Conclusions: Patients with asbestosis have multiple comorbidities. Prevention and treatment of CAD and LC may influence the prognosis of asbestosis patients.

Kokoelmat